Inovio Pharmaceuticals (NASDAQ:INO) Receives Neutral Rating from HC Wainwright
HC Wainwright reiterated their neutral rating on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $3.00 price objective on the biopharmaceutical company’s stock. Separately, JMP Securities reissued a “market outperform” rating and set a $18.00 price objective on shares of Inovio […]
HC Wainwright reiterated their neutral rating on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $3.00 price objective on the biopharmaceutical company’s stock. Separately, JMP Securities reissued a “market outperform” rating and set a $18.00 price objective on shares of Inovio […]
